FloraWorks

In The News

THE CANNABIS CONVERSATION - EPISODE #79

Investigating CBN with Alan Ridgeway, Co-Founder and CEO at FloraWorks

This week we’re joined by Alan Ridgeway, Co-Founder and CEO at FloraWorks – a Canadian hemp refinement laboratory offering specialized cannabinoid formulations. Together, we explore one of the ‘minor’ cannabinoids – CBN. We take a look at its incredible therapeutic properties, mechanism of action, and its potential as a market disruptor.

FORBES

Seven Intrinsic Questions With CEO Of FloraWorks: Alan Ridgeway

“I truly believe this molecule (CBN) has the potential to be an important wellness product that can help a lot of people and I’m extremely excited to work with the team we have at FloraWorks to bring it to market.” 

– Alan Ridgeway

YAHOO FINANCE

Also Known as “The Sleep Cannabinoid”, Cannabinol (CBN) Is Now Available in Commercial Quantities

This rare cannabinoid is taking the wellness and CBD markets by storm as new research and anecdotal evidence expands.

PORTLAND BUSINESS JOURNAL

This Oregon company is betting on the next next big thing in hemp.

Milwaukie startup thinks it’s cracked the code on an elusive cannabinoid, CBN.

Looking for Cannabinol Isolate?

Contact a FloraWorks Sales Representative

CBN

Looking for a custom product development solution?

Contact a FloraWorks Partnership Representative 

Looking for Premium Cannabinoid Compounds?

 

Contact a FloraWorks Sales Representative 

General Inquiries

We're here to answer any questions you may have.

Looking for Cannabidiol Isolate?

Contact a FloraWorks Sales Representative

CBD

Looking for Cannabigerol Isolate?

Contact a FloraWorks Sales Representative

CBG

General Inquiries

We're here to answer any questions you may have.

LET'S TALK

Looking for Cannabichromene Isolate?

Contact a FloraWorks Sales Representative

CBC